Search
Enlonstobart
go.drugbank.com/drugs/DB21890Investigational[A274486] It targets the programmed cell death protein 1 (PD-1), is being developed by the CSPC Pharmaceutical Group for the treatment of advanced cervical cancer and other solid tumours.
Metrifonate
go.drugbank.com/drugs/DB11473ExperimentalVet approvedIt is a prodrug which is activated non-enzymatically into 2,2-dichlorovinyl dimethyl phosphate.
Etiracetam
go.drugbank.com/drugs/DB11868ExperimentalEtiracetam is under investigation in clinical trial NCT01137110 (Comparison of Short Duration Levetiracetam to Extended Course for Seizure Prophylaxis After Subarachnoid Hemorrhage (SAH)).
Moschus berezovskii musk sac resin
go.drugbank.com/drugs/DB14247InvestigationalIt is not an approved drug.
Swertia japonica whole flowering
go.drugbank.com/drugs/DB14268InvestigationalIt is not an approved drug.
GW-468816
go.drugbank.com/drugs/DB15099ExperimentalGW-468816 is under investigation in clinical trial NCT00218465 (Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to Smoking).
Categories: Receptors, N-Methyl-D-Aspartate, antagonists & inhibitorsLivoletide
go.drugbank.com/drugs/DB15188InvestigationalLivoletide is under investigation in clinical trial NCT03790865 (Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome).